Conference Update View All
Meeting Highlight View All

Drugging the undruggable KRAS with sotorasib, the first-in-class KRASG12C inhibitor for advanced NSCLC


Dr. Bob T. Li

Medical Oncologist,
Physician Ambassador to China and Asia-Pacific,
Bobst International Center
Co-Director, Thoracic Liquid Biopsy Program
Chief Scientific Officer, MSK Direct,
Memorial Sloan Kettering Cancer Center,
New York, United States

Infographics View All

Potential risk factors for developing nerve damage after cancer treatment

12 May 2021